DR 261 (156516-78-8)

Other Product

• Hydrochlorofluorocarbon-261 (HCFC-261)
• EI 261
• DR 273
• DR 260
• DR 28
• C. I. Acid red 261
• benzyl-N,4-diMethylpiperidin-3-aMine dihydrochloride(dr>98/2)
• Antigen HLA-DR-BON(human clone HLA-DRB1*BON b-chain protein moiety reduced) (9CI)
• 3-(Dr-1tF,2cF,3rF,4-tetrahydroxy-but-catF-yl)-1H-quinoxalin-2-one
• 1H-Pyrrole-1-heptanoicacid, b,d-dihydroxy-2-(1-methylethyl)-4,5-diphenyl-3-[(phenylamino)carbonyl]-,(bR,dR)-
• 1-Naphthaleneheptanoicacid, 1,2,3,5,6,7,8,8a-octahydro-b,d,3-trihydroxy-2,6-dimethyl-,[1R-[1a(bR*,dR*),2a,3b,6b,8aa]]- (9CI)
• 1-Naphthaleneheptanoicacid, 1,2,3,5,6,7,8,8a-octahydro-b,d,3-trihydroxy-2-methyl-,monosodium salt, [1R-[1a(bR*,dR*),2a,3b,8aa]]- (9CI)
• 1H-Pyrrole-1-heptanoicacid, 2-(4-fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,(bR,dR)-rel-
• 1H-Pyrrole-1-heptanoicacid, 2-(4-fluorophenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-,sodium salt (1:1), (bR,dR)-
• 1-Naphthaleneheptanoicacid, 8-(2,2-dimethyl-1-oxobutoxy)-1,2,6,7,8,8a-hexahydro-b,d-dihydroxy-2,6-dimethyl-, ammonium salt (1:1), (bR,dR,1S,2S,6R,8S,8aR)-
• 1-Naphthaleneheptanoicacid, 1,2,6,7,8,8a-hexahydro-b,d,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-,4-(nitrooxy)butyl ester, (bR,dR,1S,2S,6S,8S,8aR)-
• 1-Naphthaleneheptanoicacid, 1,2,6,7,8,8a-hexahydro-b,d,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-,(bR,dR,1S,2S,6S,8S,8aR)-
• Immunoglobulin G1,anti-(human histocompatibility antigen HLA-DR) (human-mouse monoclonal Hu1D10 g1-chain), disulfide withhuman-mouse monoclonal Hu1D10 light chain, dimer
• 1H-Pyrrole-1-heptanoicacid, 2-(4-fluorophenyl)-b,d-dihydroxy-4-[[(4-hydroxyphenyl)amino]carbonyl]-5-(1-methylethyl)-3-phenyl-,(bR,dR)-
• 1-Naphthaleneheptanoicacid, 1,2,6,7,8,8a-hexahydro-b,d-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutoxy)-,ammonium salt (1:1), (bR,dR,1S,2S,6R,8S,8aR)-